Immunotherapy alleviates amyloid-associated synaptic pathology in an Alzheimer’s disease mouse model

Cognitive decline in Alzheimer’s disease is attributed to loss of functional synapses, most likely caused by synaptotoxic, oligomeric forms of amyloid-β. Many treatment options aim at reducing amyloid-β levels in the brain, either by decreasing its production or by increasing its clearance. We quant...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Brain
Egile Nagusiak: Dorostkar, Mario M., Burgold, Steffen, Filser, Severin, Barghorn, Stefan, Schmidt, Boris, Anumala, Upendra Rao, Hillen, Heinz, Klein, Corinna, Herms, Jochen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2014
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4240293/
https://ncbi.nlm.nih.gov/pubmed/25281869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awu280
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak